CID 16729334

5'-d(ggttttt)-3'-fi

Structural Information

Molecular Formula
C91H103N21O50P6S
SMILES
CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COP(=O)(O)O[C@H]3C[C@@H](O[C@@H]3COP(=O)(O)O[C@H]4C[C@@H](O[C@@H]4COP(=O)(O)O[C@H]5C[C@@H](O[C@@H]5COP(=O)(O)O[C@H]6C[C@@H](O[C@@H]6COP(=O)(O)O[C@H]7C[C@@H](O[C@@H]7COP(=O)(O)O[C@H]8C[C@@H](O[C@@H]8CO)N9C=NC1=C9N=C(NC1=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)N1C=C(C(=O)NC1=O)C)N(/C=C(/C)\C(=O)N)C=O)N1C=C(C(=O)NC1=O)C)OC(=S)NC1=CC(=C(C=C1)C1=C2C=CC(=O)C=C2OC2=C1C=CC(=C2)O)C(=O)O
InChI
InChI=1S/C91H103N21O50P6S/c1-37(75(92)117)22-106(36-114)65-16-53(158-165(134,135)145-30-61-54(18-67(152-61)108-24-39(3)79(119)103-88(108)127)159-164(132,133)142-28-59-51(15-66(151-59)107-23-38(2)78(118)102-87(107)126)156-91(169)97-42-6-9-45(48(12-42)84(124)125)72-46-10-7-43(115)13-49(46)148-50-14-44(116)8-11-47(50)72)60(150-65)29-143-166(136,137)160-55-19-68(109-25-40(4)80(120)104-89(109)128)153-62(55)31-146-167(138,139)161-56-20-69(110-26-41(5)81(121)105-90(110)129)154-63(56)32-147-168(140,141)162-57-21-71(112-35-96-74-77(112)99-86(94)101-83(74)123)155-64(57)33-144-163(130,131)157-52-17-70(149-58(52)27-113)111-34-95-73-76(111)98-85(93)100-82(73)122/h6-14,22-26,34-36,51-71,113,115H,15-21,27-33H2,1-5H3,(H2,92,117)(H,97,169)(H,124,125)(H,130,131)(H,132,133)(H,134,135)(H,136,137)(H,138,139)(H,140,141)(H,102,118,126)(H,103,119,127)(H,104,120,128)(H,105,121,129)(H3,93,98,100,122)(H3,94,99,101,123)/b37-22-/t51-,52-,53-,54-,55-,56-,57-,58+,59+,60+,61+,62+,63+,64+,65+,66+,67+,68+,69+,70+,71+/m0/s1
InChIKey
QHGGZHIVMILWCV-AWCRKQIDSA-N
Compound name
5-[[(2R,3S,5R)-2-[[[(2R,3S,5R)-2-[[[(2R,3S,5R)-5-[[(Z)-3-amino-2-methyl-3-oxoprop-1-enyl]-formylamino]-2-[[[(2R,3S,5R)-2-[[[(2R,3S,5R)-2-[[[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-2-(hydroxymethyl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxycarbothioylamino]-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

2507.431 Da
Monoisotopic Mass

-10.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 2508.4383 281.9
[M+Na]+ 2530.4202 292.9
[M-H]- 2506.4237 289.5
[M+NH4]+ 2525.4648 287.0
[M+K]+ 2546.3942 287.7
[M+H-H2O]+ 2490.4283 279.9
[M+HCOO]- 2552.4292 286.9
[M+CH3COO]- 2566.4449 287.6
[M+Na-2H]- 2528.4057 300.0
[M]+ 2507.4305 288.4
[M]- 2507.4315 288.4
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.